ACE2 and COVID-19: Chronic heart disease more frequent in patients hospitalized with COVID-19, compared with H1N1 (Table 1), whereas for severe cases, COVID-19 had the highest prevalence of chronic heart disease than H7N9, which might be associated with increased secretion of ACE2 in the COVID-19 compared with H7N9 and H1N1.